ISARIC provides a collaborative platform through which global, patient‐oriented clinical studies can be developed, executed and shared.
Protocols addressing the most important questions between and during epidemics of severe acute respiratory infections and other rapidly emerging public health threats are undertaken in order to generate new knowledge, maximise the availability of clinical information, and thereby save lives.
Healthcare professionals in COVID-19 hospital (Photo credit: Professor Bin Cao, China-Japan Friendship Hospital, China)
International Severe Acute Respiratory and emerging Infection Consortium
COVID-19 preparedness response timeline
ISARIC has just published the COVID response timeline to mark the amazing work carried out by all those using ISARIC’s resources and clinical data platform since the beginning of the pandemic.
The timeline showcases how the federation has taken action right from the start of the pandemic to address the most important research questions in order to further the knowledge of COVID-19, and thereby save lives.
What we do
Our purpose is to prevent illness and deaths from infectious disease outbreaks.
We are a global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases.
In December 2019, a novel coronavirus (SARS-CoV-2) emerged to cause a pandemic of a severe coronavirus disease (COVID-19). ISARIC has created tools for investigators to collect and store data in a standardised way and has supported clinical trials of treatments.
See below our featured research areas:
ISARIC member network Principal Investigator, Fernando Bozza (Oswaldo Cruz Foundation, Brazil) collaborated in a study that compared clinical data from COVID-19 hospital admissions during the first and second waves in Brazil.
A group of researchers started this project with the aims of understanding what are the core outcomes for patients living with Long COVID.
On its 10th anniversary, University of Oxford’s ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) demonstrates the crucial role of global preparedness and collaboration for advancing knowledge on infectious disease pandemics.
Event date - 10/06/2021
Plasma from patients who have recovered from SARS-CoV-2 infection (convalescent plasma) contains antibodies that can bind to and neutralise the virus.
Event date - 17/12/2020
This forum aims to review evidence and strategies for Non-invasive ventilation (NIV) in COVID, develop and promote research ideas and evidence-based practice.
Event date - 09/12/2020
Currently very little is known about the clinical, biological, psychological and socio-environmental impact of Coronavirus Disease 2019 (COVID-19). While most people have uncomplicated recoveries, some continue to live with prolonged illness and symptoms.